KDM2B/FBXL10 Targets C-Fos for Ubiquitylation and Degradation in Response to Mitogenic Stimulation

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2016 Jan 5

PMID 26725323

Citations 19

Authors

X-R Han

Z Zha

H-X Yuan

X Feng

Y-K Xia

Q-Y Lei

K-L Guan

Y Xiong

Affiliations

Soon will be listed here.

Abstract

KDM2B (also known as FBXL10) controls stem cell self-renewal, somatic cell reprogramming and senescence, and tumorigenesis. KDM2B contains multiple functional domains, including a JmjC domain that catalyzes H3K36 demethylation and a CxxC zinc-finger that recognizes CpG islands and recruits the polycomb repressive complex 1. Here, we report that KDM2B, via its F-box domain, functions as a subunit of the CUL1-RING ubiquitin ligase (CRL1/SCF(KDM2B)) complex. KDM2B targets c-Fos for polyubiquitylation and regulates c-Fos protein levels. Unlike the phosphorylation of other SCF (SKP1-CUL1-F-box)/CRL1 substrates that promotes substrates binding to F-box, epidermal growth factor (EGF)-induced c-Fos S374 phosphorylation dissociates c-Fos from KDM2B and stabilizes c-Fos protein. Non-phosphorylatable and phosphomimetic mutations at S374 result in c-Fos protein which cannot be induced by EGF or accumulates constitutively and lead to decreased or increased cell proliferation, respectively. Multiple tumor-derived KDM2B mutations impaired the function of KDM2B to target c-Fos degradation and to suppress cell proliferation. These results reveal a novel function of KDM2B in the negative regulation of cell proliferation by assembling an E3 ligase to targeting c-Fos protein degradation that is antagonized by mitogenic stimulations.

Citing Articles

SKP1-CUL1-F-box: Key molecular targets affecting disease progression.

Zeng X, Cao J, Xu J, Zhou Z, Long C, Zhou Y FASEB J. 2025; 39(2):e70326.

PMID: 39812503 PMC: 11734646. DOI: 10.1096/fj.202402816RR.

KDM2B regulates stroke injury by modulating OGT-mediated 0-GlcNAcylation of SLC7A11.

Li Y, Niu L, Zheng D, Zhang X, Feng L, Fu J Commun Biol. 2024; 7(1):1530.

PMID: 39558086 PMC: 11574022. DOI: 10.1038/s42003-024-07251-w.

Versatile JMJD proteins: juggling histones and much more.

Oh S, Janknecht R Trends Biochem Sci. 2024; 49(9):804-818.

PMID: 38926050 PMC: 11380596. DOI: 10.1016/j.tibs.2024.06.009.

The emerging roles of histone demethylases in cancers.

Tong D, Tang Y, Zhong P Cancer Metastasis Rev. 2024; 43(2):795-821.

PMID: 38227150 DOI: 10.1007/s10555-023-10160-9.

The FnBPA from methicillin-resistant promoted development of oral squamous cell carcinoma.

Kong L, Wang Z, Shou Y, Zhou X, Zong Y, Tong T J Oral Microbiol. 2022; 14(1):2098644.

PMID: 35859766 PMC: 9291692. DOI: 10.1080/20002297.2022.2098644.

References

Rauscher 3rd F, Sambucetti L, Curran T, Distel R, Spiegelman B . Common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell. 1988; 52(3):471-80. DOI: 10.1016/s0092-8674(88)80039-4. View

Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper J . SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 1996; 86(2):263-74. DOI: 10.1016/s0092-8674(00)80098-7. View

Glover J, Harrison S . Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature. 1995; 373(6511):257-61. DOI: 10.1038/373257a0. View

Okazaki K, Sagata N . The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 1995; 14(20):5048-59. PMC: 394608. DOI: 10.1002/j.1460-2075.1995.tb00187.x. View

Kottakis F, Foltopoulou P, Sanidas I, Keller P, Wronski A, Dake B . NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells. Cancer Res. 2014; 74(14):3935-46. PMC: 4454481. DOI: 10.1158/0008-5472.CAN-13-2733. View

Tsukada Y, Fang J, Erdjument-Bromage H, Warren M, Borchers C, Tempst P . Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2005; 439(7078):811-6. DOI: 10.1038/nature04433. View

Zheng N, Schulman B, Song L, Miller J, Jeffrey P, Wang P . Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature. 2002; 416(6882):703-9. DOI: 10.1038/416703a. View

Sassone-Corsi P, Ransone L, Lamph W, Verma I . Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature. 1988; 336(6200):692-5. DOI: 10.1038/336692a0. View

He J, Shen L, Wan M, Taranova O, Wu H, Zhang Y . Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes. Nat Cell Biol. 2013; 15(4):373-84. PMC: 4078788. DOI: 10.1038/ncb2702. View

10.

Pfau R, Tzatsos A, Kampranis S, Serebrennikova O, Bear S, Tsichlis P . Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci U S A. 2008; 105(6):1907-12. PMC: 2538857. DOI: 10.1073/pnas.0711865105. View

11.

Shaulian E, Karin M . AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002; 4(5):E131-6. DOI: 10.1038/ncb0502-e131. View

12.

Treisman R . Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 1995; 14(20):4905-13. PMC: 394592. DOI: 10.1002/j.1460-2075.1995.tb00173.x. View

13.

Stancovski I, Gonen H, Orian A, Schwartz A, Ciechanover A . Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol Cell Biol. 1995; 15(12):7106-16. PMC: 230966. DOI: 10.1128/MCB.15.12.7106. View

14.

Eferl R, Wagner E . AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003; 3(11):859-68. DOI: 10.1038/nrc1209. View

15.

Liang G, He J, Zhang Y . Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol. 2012; 14(5):457-66. PMC: 3544197. DOI: 10.1038/ncb2483. View

16.

Sasaki T, Kojima H, Kishimoto R, Ikeda A, Kunimoto H, Nakajima K . Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell. 2006; 24(1):63-75. DOI: 10.1016/j.molcel.2006.08.005. View

17.

Skowyra D, Craig K, Tyers M, Elledge S, Harper J . F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell. 1997; 91(2):209-19. DOI: 10.1016/s0092-8674(00)80403-1. View

18.

Greenberg M, Ziff E . Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984; 311(5985):433-8. DOI: 10.1038/311433a0. View

19.

Bakiri L, Reschke M, Gefroh H, Idarraga M, Polzer K, Zenz R . Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis. Oncogene. 2010; 30(13):1506-17. PMC: 3838948. DOI: 10.1038/onc.2010.542. View

20.

Tzatsos A, Paskaleva P, Ferrari F, Deshpande V, Stoykova S, Contino G . KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J Clin Invest. 2013; 123(2):727-39. PMC: 3561797. DOI: 10.1172/JCI64535. View